FDA Approval of Epidiolex
The FDA-approved Epidiolex, a cannabinoid-based prescription drug to treat rare and severe types of epilepsy like Dravet syndrome and Lennox-Gastaut syndrome, is one of the most important achievements in the research of CBD.
Clinical Evidence
CBD has been shown by several randomized, double-blind clinical trials to significantly decrease seizure frequency in patients whose frequency was not responsive to conventional anti-seizure drugs.
Implications
This discovery has cemented the role of CBD in modern medicine as it has demonstrated that it is a potent treatment method when supported by solid science.
Neuroprotective Effect of CBD.
Protecting Brain Health
Scientists are exploring the use of CBD as neuroprotectant especially in diseases which are marked by neurodegeneration. Its anti-oxidant and anti-inflammatory effects can be used to decrease the neuronal damage and aid the brain functions.
Ongoing Research
Alzheimer disease: There are initial research findings that CBD can have a positive impact on the formation of plaques and neuroinflammation.
Parkinson disease: It has been shown that CBD can be used in the treatment of sleep disorders and psychotic signs.
Multiple sclerosis (MS): CBD, usually used together with THC as an ingredient in Sativex, can help improve muscle spasticity.
CBD as a Skin Health and Dermatology Supplement.
Acne and Inflammation
Due to its capacity to decrease inflammation and control the amount of sebum (oil) that the skin secretes, CBD is a promising anti-inflammatory ingredient in skincare. The laboratory research has demonstrated that CBD could be used to treat acne,
by inhibiting the excessive secretion of sebum, and alleviating the inflammation.
Skin Conditions
The topical use of CBD-infused is studied in treating eczema, psoriasis, and dermatitis, in which the inflammation is a significant contribution. A large number of users testify of skin texture improvements and decreased irritation.